Stock Taper
NVST
ENVISTA HOLDINGS CORP
NYSE
$27.13
▼ DOWN 1.13% (-0.31)

KEY STATISTICS

Market Cap$4.41 B
52w High$30.42
52w Low$18.77
Dividend Yield
Frequency
P/E18.46
Volume1.21M
Shares Out.162.73M

COMPANY

LEADERSHIP

Paul A. Keel
CHIEF EXECUTIVE
Paul A. Keel

COMPENSATION 2026

Salary$1,100,000
Stock Awards$10,700,076
Incentive Plan Pay$1,086,144
All Other Comp.$368,578
Total$24,236,357

ABOUT

SECTOR
Healthcare
WENT PUBLIC
September 18, 2019
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
12,000

PRICE TARGET

Target High$34.00
Target Low$23.00
Target Median$29.00
Target Consensus$29.14

UPCOMING EARNINGS

DateNov 4, 2026
DayWednesday
Rev. Est.$695.87M
NOV
4
WED

PRICE

$27.13 ▼ DOWN 1.13% (−$0.31)
$27.15$27.30$27.459:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM27.13

About Envista Holdings Corp

http://www.envistaco.com ↗

Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating, and preventing dental conditions through its Specialty Products & Technologies and Equipment & Consumables segments, serving dental professionals worldwide.

INDUSTRY

Medical - Instruments & Supplies

A PRODUCT ENVISTA HOLDINGS CORP IS KNOWN FOR

DEXIS Ti2 Intraoral Sensor
DEXIS Ti2 Intraoral Sensor

The DEXIS Ti2, launched in May 2024, is an AI-enabled intraoral sensor that automatically detects six dental findings, advancing Envista's AI-driven digital dentistry under the DEXIS brand.

Revenue by Products

IconPRODUCTQ3-2023Q4-2023Q1-2024Q4-2024
Specialty Products and Technologies$399.5M $825.9M $408.7M $1.21B
Equipment and Consumables$231.8M $446.9M $214.9M $679.3M

Revenue by Geography

MapREGIONQ2-2025Q3-2025Q1-2026Q2-2026
North America$347.9M $348.1M $364.2M $364.7M
Western Europe$154.1M $139.1M $184.8M $165.3M

RATINGS SNAPSHOT

Overall rating: B+

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity5
Return On Assets5
Debt To Equity2
Price To Earnings1
Price To Book1
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Pete Sessions
Pete Sessions
Sale (Full)
2024-06-06

INSIDER TRADES

OFFICER: PRESIDENT, DIAGNOSTICS
Befidi Robert
Sale · 5.1K shares
2026-08-25
OFFICER: CHIEF FINANCIAL OFFICER
Hammes Eric D.
Sale · 10.9K shares
2026-08-25
OFFICER: PRESIDENT, NOBEL BIOCARE
Nilsson Stefan
Sale · 804 shares
2026-08-25
OFFICER: PRESIDENT, ORTHODONTICS
Acurio Veronica
Sale · 7.7K shares
2026-08-25

MOST RECENT ANALYST GRADES

GRADE SUMMARY
NEUTRAL 4
OUTPERFORM 2
EQUAL WEIGHT 2
OVERWEIGHT 1
BUY 1
10 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
APGE$134.97COMPARE
DYN$25.07COMPARE
CON$34.26COMPARE
ICUI$175.10COMPARE
GRAL$80.00COMPARE
ALHC$13.62COMPARE
PRVA$20.79COMPARE
SUPN$43.73COMPARE